DOSING REGIMEN OF COMBINATION OF ANTI-CD20 AND ANTI-BLYS ANTIBODIES

• 收藏
• 分享

专利权人:

GLAXOSMITHKLINE INTELLECTUAL PROPERTY MANAGEMENT LIMITED

发明人:

HENDERSON, ROBERT B.

申请号：

CA2999695

公开号：

CA2999695A1

申请日:

2016.09.21

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The present invention relates toa CD20 binding antibody which is capable of depleting B cells, and a BLyS binding antibody which is capable of antagonizing BLyS, as a combination for use in the treatment of an autoimmune disorder.The invention also relates to dosages, duration of treatment and time lapses between administration of the CD20 binding antibody which is capable of depleting B cells, and the BLyS binding antibody which is capable of antagonizing BLyS.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/